強気
$0.42
シナリオ価格
$1.850
+0.263 (+14.20%)終値時点
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers.
Biomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

BiomX to Rebrand as Tessera, Launches No-Code AI Command Platform

BiomX to Rebrand as Tessera Defense and Homeland Security Inc.

BiomX Subsidiary Secures $300,000 Defense Order

BiomX Acquires 10% Stake in Motomea to Enhance Drone Testing Capabilities

BiomX Amends Terms of Zorronet Acquisition
Tessera Defense and Homeland Security Inc., formerly BiomX Inc., is a technology company focused on defense and homeland security. The Company, through its subsidiaries and investments, develops and deploys threat detection, AI-powered analysis and related technologies for defense, security and critical infrastructure customers. It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Biomx Inc (PHGE) is currently not a strong buy due to its significant losses and lack of revenue. The stock is trading at $0.15, down 93.10% year-to-date, indicating severe financial distress. Although the recent acquisition news may provide some positive outlook, the company reported a net income loss of $37.72 million in Q2 2026, which raises concerns about its financial stability. The RSI is at 66.55, suggesting it is nearing overbought territory, which could lead to a pullback. The main risk is the ongoing negative earnings trend, with a forward P/E ratio of 0, indicating no expected profitability in the near future.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。